Back to Search Start Over

Bedside cannulation for veno-venous extracorporeal membrane oxygenation using portable X-ray system in a coronavirus disease patient.

Authors :
Kondo T
Kuwayama T
Hiraiwa H
Kasugai D
Goto Y
Numaguchi A
Katsu T
Matsui T
Hashimoto N
Tanaka A
Morimoto R
Okumura T
Murohara T
Source :
Journal of cardiology cases [J Cardiol Cases] 2022 Mar; Vol. 25 (3), pp. 185-187. Date of Electronic Publication: 2021 Sep 25.
Publication Year :
2022

Abstract

Transportation of patients with coronavirus disease (COVID)-19 outside isolation rooms should be avoided to prevent further spread of the disease. Here, we report a safe and accurate bedside cannulation method for veno-venous extracorporeal membrane oxygenation (VV-ECMO) in a COVID-19 patient in the intensive care unit. A 71-year-old man was admitted to our hospital and diagnosed as having COVID-19 pneumonia. We decided to initiate VV-ECMO therapy because maintaining blood oxygen saturation was difficult despite the mechanical ventilation. We placed two flat-panel detectors behind the patient's chest and the right inguinal area. We repeatedly imaged and monitored insertion of wires and cannulas using a portable X-ray system. Cannulas were successfully inserted in the appropriate position, and VV-ECMO was initiated without any complications. < Learning objective: Transportation of patients with coronavirus disease outside isolation rooms carries the risk of further spread of the disease. By repeatedly acquiring images using a portable X-ray system, safe and accurate cannulation for veno-venous extracorporeal membrane oxygenation cannulation can be performed at the bedside in the intensive care unit.>.<br />Competing Interests: T.O. received lecture fees from Ono Yakuhin, Medtronics, and Otsuka and received research grants from Ono Yakuhin, Bayer, Daiichi-Sankyo, and Amgen Astellas (not in connection with the submitted work). T.M. received lecture fees and unrestricted research grants from the Department of Cardiology at Nagoya University Graduate School of Medicine, Bayer, Daiichi-Sankyo, Dainippon Sumitomo, Kowa, MSD, Mitsubishi Tanabe, Boehringer Ingelheim, Novartis, Pfizer, Sanofi-Aventis, Takeda, Astellas, Otsuka, and Teijin.<br /> (© 2021 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1878-5409
Volume :
25
Issue :
3
Database :
MEDLINE
Journal :
Journal of cardiology cases
Publication Type :
Report
Accession number :
34603563
Full Text :
https://doi.org/10.1016/j.jccase.2021.09.008